News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
Christine Rini, PhD, a social/health psychologist and highly respected expert in cancer survivorship has joined the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as director of its Cancer Survivorship Institute (CSI).
Feinberg partnered with Nature Genetics and Nature Medicine to host the Chicago Science 2019: Epigenetics and Genome Editing conference.
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
As we look back on a period of dynamic growth and progress, our commitment to advancing life-changing research has never been stronger. Collaborating across disciplines, Lurie Cancer Center’s world-class specialists are transforming discoveries into innovative patient-centered cancer care.
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, was named a Pew Biomedical Scholar. Prindle will receive a four-year, $300,000 grant to study the genetic signals that prompt bacteria to migrate from densely-packed communities called biofilms.
Constadina Arvanitis, PhD, research associate professor of Cell and Developmental Biology, has been named director of the Center for Advanced Microscopy and Nikon Imaging Center.
On Sunday, June 2, more than 3,000 participants gathered in Chicago’s Grant Park for the 2019 Cancer Survivors’ Celebration Walk and 5K. Held on National Cancer Survivors Day, Lurie Cancer Center’s signature event is a source of hope and inspiration for people who have faced, or are facing cancer.
On May 17, 350 friends and supporters gathered for the annual Minds Matter Benefit Dinner to raise funds for the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital. This year’s fundraiser at Chicago’s urban-chic Revel Fulton Market, raised more than half a million dollars to support the institute and patients affected by brain and spinal tumors.
A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present the latest clinical research impacting cancer care at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
Jaehyuk Choi, MD, PhD, was selected to receive a 2019 Young Investigator Award from the National Comprehensive Cancer Network (NCCN) and the NCCN Foundation to advance his work on the Genomic Determinants of Responses to Immunotherapy in Merkel Cell Carcinoma.
The structure of spherical nucleic acids has the potential to improve the effectiveness of vaccines as well as cancer immunotherapies, according to a new study.
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.
High doses of vitamin D, in combination with chemotherapy, may improve progression-free survival in patients with advanced colorectal cancer, according to a clinical trial published in JAMA.
A delegation from the National Comprehensive Cancer Network, including Northwestern oncology leaders, recently met with health leaders in Bolivia to begin generating cancer treatment recommendations to fit the country’s unique needs.
See more news in the article archive.